Who
Dominic Smethurst
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Corbus Pharmaceuticals Holdings; Chief Medical Officer, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $250K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 21 Aug 2020
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $51K6,097 at $8.30 | filing |
| 2 Mar 2026filed 4 Mar 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $51K6,097 at $8.30 | filing |
| 3 Feb 2026filed 4 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $27K3,285 at $8.09 | filing |
| 3 Feb 2026filed 4 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $27K3,285 at $8.09 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —28,365 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,095 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,095 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —28,365 at $0.00 | filing |
| 6 Mar 2025filed 7 Mar 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $43K6,393 at $6.78 | filing |
| 31 Jan 2025filed 4 Feb 2025 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,200 at $0.00 | filing |
| 31 Jan 2025filed 4 Feb 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —27,200 at $0.00 | filing |
| 27 Feb 2024filed 29 Feb 2024 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 27 Feb 2024filed 29 Feb 2024 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $52K1,801 at $29.06 | filing |
| 3 Jan 2022filed 5 Jan 2022 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 23 Sep 2021filed 27 Sep 2021 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 23 Sep 2021filed 27 Sep 2021 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code M | $111K6,000 at $18.55 | filing |
News
No headline names them, or the companies they trade most, lately.